Veneno Technologies, a Tsukuba City, Japan-based Novel DRP Drug Discovery company, raised $2M in Seed funding.
Bokksu, a New York and Tokyo, Japan-based Japanese snack subscription and e-grocer, raised $22m in Series A funding at a $100M valuation.
Accenture (NYSE: ACN) completed the acquisition of Tambourine, a Tokyo, Japan-based e-commerce customer experience agency with capabilities in cloud-based technologies in Japan.
Nudge Inc., a Tokyo, Japan-based credit-card provider, expanded its Pre-Series-A funding round.
Accenture (NYSE: ACN) is to acquire Tambourine, a Tokyo, Japan-based e-commerce customer experience agency with capabilities in cloud-based technologies.
Olympus Corporation (Tokyo: 7733), a medical technology company, has launched Olympus Innovation Ventures.
oVice, a Nanao, Japan-based company provider of tools for remote work and events, raised $18M in Series A funding.
Bisu, a Tokyo, Japan-based health tech startup, raised $3.2M in Seed funding.
SmartRyde, Inc., a Tokyo, Japan-based marketplace to connect local transportation operators and online travel agencies (OTAs), raised approx. $1.6m in Series A funding.
SmartNews Inc., a Japanese global leader in redefining information and news discovery, raised $230m in Series F funding.
Octopus Network, a Tokyo, Japan-based multi-chain cryptonetwork for bootstrapping and running appchains, raised $5M in Series A funding.
Tetavi, a Los Angeles, CA-based volumetric technology platform, closed a $20m venture funding round.
Accenture (NYSE: ACN) completed the acquisition of DI Square’s consulting capabilities for product lifecycle management (PLM) and application lifecycle management (ALM) systems integration.
OriCiro Genomics, a Tokyo, Japan-based pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapy and synthetic biology, raised ¥800m in Series B financing.
Telexistence, Inc., a Tokyo, Japan-based innovator in remote-controlled robotics with artificial intelligence, closed a $20M Series A-2 financing.